Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of +47.31% and +71.24%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

MGNXPositive Net Change VRNOPositive Net Change

Zacks Equity Research

Will Bentley Systems (BSY) Gain on Rising Earnings Estimates?

Bentley Systems, Incorporated (BSY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BSYPositive Net Change

Zacks Equity Research

Can FMC Technologies (FTI) Run Higher on Rising Earnings Estimates?

FMC Technologies (FTI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

FTIPositive Net Change

Zacks Equity Research

All You Need to Know About Ross Stores (ROST) Rating Upgrade to Buy

Ross Stores (ROST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ROSTPositive Net Change

Zacks Equity Research

Global Partners (GLP) Upgraded to Buy: Here's Why

Global Partners (GLP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GLPPositive Net Change

Zacks Equity Research

All You Need to Know About RenaissanceRe (RNR) Rating Upgrade to Buy

RenaissanceRe (RNR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

RNRPositive Net Change

Zacks Equity Research

All You Need to Know About Citigroup (C) Rating Upgrade to Buy

Citigroup (C) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CNegative Net Change

Zacks Equity Research

Nicox (NICXF) Upgraded to Buy: Here's Why

Nicox (NICXF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NICXFNo Net Change

Zacks Equity Research

Everus Construction Group, Inc. (ECG) Upgraded to Strong Buy: Here's Why

Everus Construction Group, Inc. (ECG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ECGNegative Net Change

Zacks Equity Research

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why

Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BFRIPositive Net Change